Clinical Trial Update: A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis [Phase 3]

View source ↗

Summary

Phase 3 clinical trial protocol evaluating icotrokinra therapy for moderately to severely active ulcerative colitis in adults and adolescents; recruitment is on…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• Icotrokinra (JNJ-77242113)

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Colitis, Ulcerative | Phase 3 | Status: RECRUITING